Press Releases

Adult Intraventricular Haemorrhage (IVH) Market is Forecasted to Hit US$ 3,462.5 Mn By 2031 | CAGR 5.13%

Global Adult Intraventricular Haemorrhage Market is expected to reach US$ 3,462.5 Mn in 2031 with a growth rate of 5.13%. The Adult Intraventricular H

  • Date: 16 Apr, 2024
  • Author: Sagar Karlekar
Epilepsy Market is Forecasted to Hit US$ 2.7 Mn By 2031 | CAGR 3.2%

Global Epilepsy Market is expected to reach US$ 2.7 Bn in 2031 with a growth rate of 3.2%. The Epilepsy Market is a part of the medical devices and ph

  • Date: 15 Apr, 2024
  • Author: Sagar Karlekar
Atopic Dermatitis Market is Forecasted to Hit US$ 28.7 Bn By 2031 | CAGR 13.8%

Atopic Dermatitis Market Expected to achieve US$ 28.7 Bn by 2031, growing at a CAGR of 13.8% from 2024 to 2031. The global atopic dermatitis market, w

  • Date: 15 Apr, 2024
  • Author: Sagar Karlekar
Age-related Vision Dysfunction Market is Forecasted to Hit US$ 126.6 Bn By 2031 | CAGR 6.8%

Global Age-related Vision Dysfunction Market is expected to reach US$ 126.6 Bn in 2031 with a growth rate of 6.8%. This market encompasses medical dev

  • Date: 15 Apr, 2024
  • Author: Sagar Karlekar
Acute Ischemic Stroke (AIS) Market is Forecasted to Hit US$ 16,470 Mn By 2031 | CAGR 8.7%

Global Acute Ischemic Stroke (AIS) Market is expected to reach US$ 16,470 Mn in 2031 with a growth rate of 8.7%. The Acute Ischemic Stroke (AIS) marke

  • Date: 15 Apr, 2024
  • Author: Sagar Karlekar
Active Implantable Medical Devices Market is Forecasted to Hit US$ 47.2 Bn By 2031 | CAGR 9.7%

The Global Active Implantable Medical Devices Market is expected to reach US$ 47.2 Bn in 2031, growing at a CAGR of 9.7% from 2024 to 2031. Active imp

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Absorbable Hemostats Market is Forecasted to Hit US$ 3.9 Bn By 2031 | CAGR 8.2%

The Global Absorbable Hemostats Market is expected to reach US$ 3.9 Bn in 2031, growing at a CAGR of 8.2% from 2024 to 2031. Absorbable hemostats are

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Ablation Devices Market is Forecasted to Hit US$ 10.4 Bn By 2031 | CAGR 6.3%

Global Ablation Devices Market is expected to reach US$10.4 Bn in 2031 with a growth rate of 6.3%. The Ablation Devices Market is a part of the medica

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
3D Cardiac Mapping System Market is Forecasted to Hit US$ 3,243.1 Mn By 2031 | CAGR 8.8%

3D Cardiac Mapping System Market Expected to Achieve US $ 3,243.1 Bn by 2031 with a growing CAGR 8.8% during the forecast period of 2024 to 2031. The

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Vernal Keratoconjunctivitis Market is Forecasted to Hit US$ 2.7 Bn By 2031 | CAGR 10.5%

Vernal Keratoconjunctivitis Market Expected to Achieve US$ 2.7 Bn by 2031 with growing of CAGR 10.5% during the forecast period. The global Vernal Ker

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Ulcerative Colitis Market is Forecasted to Hit US$ 10.6 Bn By 2031 | CAGR 5.9%

Global Ulcerative Colitis Market is expected to reach US$ 10.6 Bn in 2031 with a growth rate of 5.9%. The ulcerative colitis market is part of the pha

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Soft Tissue Sarcoma Market is Forecasted to Hit US$ 10,047.7 Mn By 2031 | CAGR 5.8%

Global Soft Tissue Sarcoma Market is expected to reach US$ 10,047.7 Mn in 2031 with a growth rate of 5.8%. The Soft Tissue Sarcoma Market falls under

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Diabetic Kidney Disease (DKD) Market is Forecasted to Hit US$ 13,148.5 Mn By 2031 | CAGR 7.8%

Global Diabetic Kidney Disease (DKD) Market is expected to reach US$ 13,148.8 Mn in 2031 with a growth rate of 7.8%. The DKD market falls under the ph

  • Date: 14 Apr, 2024
  • Author: Sagar Karlekar
Cutaneous T-Cell Lymphoma (CTCL) Market is Forecasted to Hit US$ 1,204.3 Mn By 2031 | CAGR 9.1%

Global Cutaneous T-Cell Lymphoma (CTCL) Market is expected to reach US$ 1,204.3 Mn in 2031, growing at a CAGR of 9.1% from 2024 to 2031. CTCL is a rar

  • Date: 13 Apr, 2024
  • Author: Sagar Karlekar
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market is Forecasted to Hit US$ 19.9 Bn By 2031 | CAGR 8.7%

The Global Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market, belonging to the pharmaceuticals industry, is projected to reach US$ 19.9 billion by 203

  • Date: 13 Apr, 2024
  • Author: Sagar Karlekar